Zobrazeno 1 - 10
of 17
pro vyhledávání: '"November McGarvey"'
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Cancer represents a significant source of disease burden in the United States (US), both clinically and economically. Diagnosis and treatment of cancer at earlier stages may reduce this burden. To better understand potential impac
Externí odkaz:
https://doaj.org/article/0142e5204913434b98771e997aaea951
Publikováno v:
Preventive Medicine Reports, Vol 30, Iss , Pp 102046- (2022)
This study aimed to comprehensively assess breast, colorectal, cervical, lung, and prostate cancer screening rates and trends in the United States over time among individuals for whom screening is recommended by the United States Preventive Services
Externí odkaz:
https://doaj.org/article/d89c0af8d45a4d06b146d52b0646b77e
Autor:
November McGarvey, Hairong Xu
Publikováno v:
Journal of Health Economics and Outcomes Research, Vol 3, Iss 2 (2015)
**Background:** Anemia is a common complication among patients with cancer receiving chemotherapy and can cause significant costs to health plans. **Objective:** The objective of this study is to estimate the annual budget impact of drug treatment a
Externí odkaz:
https://doaj.org/article/a568dd51b7f94c26b0eaf770fa9668c7
Autor:
Jeremy S. Abramson, Corey Pelletier, Yeonhee Kim, Jacob Garcia, Tanya Siddiqi, Christine Dehner, Matthew Gitlin, Sophie Snyder, November McGarvey, Andy Nguyen, Monika P. Jun
Publikováno v:
Blood Adv
Chimeric antigen receptor (CAR) T-cell therapies have demonstrated high response rates in patients with relapsed/refractory large B-cell lymphoma (LBCL); however, these therapies are associated with 2 CAR T cell–specific potentially severe adverse
Autor:
Christopher E. Dandoy, Wan H. Tsong, Kaushik Sarikonda, November McGarvey, Miguel-Angel Perales
Publikováno v:
Transplantation and Cellular Therapy. 29:282.e1-282.e9
Hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) is a serious complication of the transplant process that has consistently been associated with a substantial increase in morbidity and mortality compared to HSCT pati
Autor:
November McGarvey, Thomas Carattini, Brian Ung, Timothy B. Campbell, Ken Imanak, Pallavi Patwardhan
Publikováno v:
Blood. 140:10947-10948
Autor:
November McGarvey, Brian Ung, Thomas Carattini, Timothy Campbell, Abraham Lee, Pallavi Patwardhan
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S181
Autor:
November McGarvey, Corey Pelletier, John E. Godwin, James Lymp, Matthew Gitlin, M. Lia Palomba, Monika Parisi Jun, Andy Nguyen, Scott J Keating
Publikováno v:
Leuk Lymphoma
This retrospective study estimated postinfusion health care resource utilization (HCRU) by site of care among 303 patients with relapsed/refractory large B-cell lymphoma who received third- or later-line treatment with lisocabtagene maraleucel (liso-
Autor:
November McGarvey, George Z. Fadda, Andy Nguyen, Matthew Gitlin, Michael J. Germain, Akhtar Ashfaq, Charles W. Bishop, Varshasb Broumand
Publikováno v:
American journal of nephrology. 52(10-11)
Introduction: The safety and efficacy of extended-release calcifediol (ERC) as a treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency (VDI) has been demonstrated in pr
Autor:
Michael J. Germain, Subir K Paul, George Fadda, Matthew Gitlin, Akhtar Ashfaq, November McGarvey, Andy Nguyen, Varshasb Broumand
Publikováno v:
Nephrology Dialysis Transplantation. 35
Background and Aims Extended-release calcifediol (ERC), active vitamin D analogs (VDA), and nutritional vitamin D (NVD) are the predominant vitamin D therapies (VDTs) commonly used for treatment (Tx) of secondary hyperparathyroidism (SHPT) in adults